In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells—one ...

NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or the "Company"), a clinical-stage biotechnology company advancing regenerative ...

Figure 1 Human Continuum Inc. Appoints Dr. Omar K. Sial, Ph.D., as its Chief Scientific Officer. New York, N.Y., Jan. 22, ...

This review innovatively proposes the use of electrospinning to fabricate electroactive fibrous scaffolds, which mimic the structure of the extracellular matrix while providing electrical activity, ...

A team at Johns Hopkins Medicine has focused their work on myelin development using oligodendrocytes to help study conditions like MS.

New evidence shows that precursors of myelin-producing cells — one of the few #brain cell types that continue to be produced ...

New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of ...

Axogen (Nasdaq: AXGN) is focused on the science, development and commercialization of technologies for peripheral nerve repair. With a mission to make nerve repair the expected standard of care, ...

In experiments with mice, Johns Hopkins Medicine scientists report new evidence that precursors of myelin-producing cells - one of the few brain cell types that continue to be produced in the adult ...

Five years in the making, the City of London is set to find out if its equity market reforms can deliver results. An outperformance of UK stocks, new listing rules taking effect and green shoots in ...